| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| MAXCYTE, INC. | Chief Commercial Officer | Common Stock | 59,439 | $188,974 | $3.18 | 18 Mar 2025 | Direct |
| MAXCYTE, INC. | Chief Commercial Officer | Employee Stock Option (right to buy) | 138,500 | 14 Mar 2025 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| MXCT | MAXCYTE, INC. | 18 Mar 2025 | 1 | -$3,850 | 4 | Chief Commercial Officer | 20 Mar 2025, 18:49 |
| MXCT | MAXCYTE, INC. | 14 Mar 2025 | 2 | $0 | 4 | Chief Commercial Officer | 18 Mar 2025, 20:51 |
| MXCT | MAXCYTE, INC. | 16 Sep 2024 | 2 | $0 | 4 | Chief Commercial Officer | 18 Sep 2024, 16:34 |
| MXCT | MAXCYTE, INC. | 11 Sep 2024 | 0 | $0 | 3 | Chief Commercial Officer | 18 Sep 2024, 16:28 |